A service of StreetInsider.com
Welcome

Most Popular

AAPL 222.25
C 3.90
GOOG 560.00
BAC 16.82
RIMM 73.06

Recently Added

CCLTF 9.20
KCAP 5.51
NWM 0.01
CNYD 13.05
WNC 6.79

Gaining Speed

NWM 0.01
KCAP 5.51
CCLTF 9.20
CNYD 13.05
BRLI 43.85
12.27 +0.28 (2.38%) THRX

Click Here to Receive Instant E-mail and RSS Alerts

Stock Details

Last Trade:12.27 Change:+0.28 (2.38%) Prev Close:11.99 Open: 11.75 Days Range:11.75 – 12.48 52 Week Range: 9.62 - 18.56 Volume:3095077 P/E: N/A
EPS:-1.35





Recent Blog Posts

Blog Posts on 01/31/10 at 6:55am
AstraZeneca to Ax 8,000 More Workers: Biotech's Latest Mishaps
Blog Posts on 11/30/09 at 2:10pm
BioMed Updates: Merck KGaA, BioMarin, Cytori and Theravance
Blog Posts on 11/26/09 at 6:19am
Theravance, Inc.: Wait to Buy on Dip
Blog Posts on 11/17/09 at 9:42am
Baupost Group's Q3 Portfolio: Two Changes of Note
Blog Posts on 08/20/09 at 7:31am
Baupost Group's Massive Position in CapitalSource
Blog Posts on 07/27/09 at 4:14am
FDA Calendar: 2H09 Binary Event Trades
Blog Posts on 07/08/09 at 10:13am
15 Overvalued Small Caps from Russell 2000
Blog Posts on 06/16/09 at 3:37pm
2009 Looking Good for Theravance
Blog Posts on 06/16/09 at 5:50am
FDA Calendar: 18 Hot Summer Trades
Blog Posts on 06/01/09 at 9:40am
Klarman's Baupost Group Bets Big on Capitalsource, News Corp.
Blog Posts on 04/26/09 at 1:26am
FDA, Clinical Trial Updates: Pro-Pharma Looks Promising
Blog Posts on 04/24/09 at 3:29pm
Theravance Narrows Its Losses
Blog Posts on 04/20/09 at 11:02am
20 'Bathwater Babies' and 15 'Dogs with Fleas' for the Week
Blog Posts on 04/07/09 at 4:28am
FDA, Clinical Trial Calendar Updates
Blog Posts on 04/07/09 at 4:28am
FDA, Clinical Trial Calendar Updates: Theravance, Gilead, Teva, Alnylam, ReNeuron
Blog Posts on 03/17/09 at 12:30pm
Tudor Investment Takes New Positions in Financials, Among Others
Blog Posts on 02/20/09 at 3:09pm
Seth Klarman's Best Ideas (for Now)
Blog Posts on 02/12/09 at 9:08pm
Theravance, Inc. Q4 2008 Earnings Call Transcript
Blog Posts on 02/05/09 at 7:51am
Top Pre-Market Analyst Upgrades (AEZS, AKAM, CNQR, HK, SJT, SGMO, THRX)
Blog Posts on 12/30/08 at 4:57am
Hedge Fund Tracking: Seth Klarman & Baupost Group, Q3 2008
Blog Posts on 12/01/08 at 5:23am
Three-Month, Updated FDA Decision Calendar
Blog Posts on 11/22/08 at 1:12pm
73 Decision Dates on Updated FDA Calendar
Blog Posts on 08/21/08 at 7:17am
15 Value Hedge Funds Portfolio Update
Blog Posts on 08/11/08 at 7:48am
Theravance, Inc. Q2 2008 Earnings Call Transcript
Blog Posts on 07/18/08 at 6:00pm
Market highlights for next week: Major earnings releases
Blog Posts on 05/19/08 at 9:24am
Baupost Group - Portfolio Holdings
Blog Posts on 01/11/08 at 3:02am
FDA Sets Date for Theravance Drug Review
Blog Posts on 10/05/07 at 4:05pm
Market highlights for next week: YUM, AA, COST, PEP to report
Blog Posts on 08/21/07 at 10:45am
Analyst initiations: AKAM, BBBY, MFE and WSM